TARI AM[au] - Search Results

Year	Number of Results
1994	2
1996	1
1997	2
1998	1
1999	3
2000	4
2001	4
2002	9
2003	5
2004	9
2005	5
2006	1
2007	5
2008	4
2009	3
2010	1
2011	2
2012	1
2013	1
2022	0

1

Bcl-2-related antisense therapy.

Gutiérrez-Puente Y, Zapata-Benavides P, Tari AM, López-Berestein G. Gutiérrez-Puente Y, et al. Among authors: tari am. Semin Oncol. 2002 Jun;29(3 Suppl 11):71-6. doi: 10.1053/sonc.2002.34058. Semin Oncol. 2002. PMID: 12138400 Review.

2

GRB2: a pivotal protein in signal transduction.

Tari AM, Lopez-Berestein G. Tari AM, et al. Semin Oncol. 2001 Oct;28(5 Suppl 16):142-7. doi: 10.1016/s0093-7754(01)90291-x. Semin Oncol. 2001. PMID: 11706405 Review.

3

How retinoids regulate breast cancer cell proliferation and apoptosis.

Simeone AM, Tari AM. Simeone AM, et al. Among authors: tari am. Cell Mol Life Sci. 2004 Jun;61(12):1475-84. doi: 10.1007/s00018-004-4002-6. Cell Mol Life Sci. 2004. PMID: 15197471 Review.

4

Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis.

Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK, Lewis VO, Ma J, Stafford RJ, Tari AM, Hortobagyi GN, Ueno NT. Costelloe CM, et al. Among authors: tari am. Lancet Oncol. 2009 Jun;10(6):606-14. doi: 10.1016/S1470-2045(09)70088-9. Lancet Oncol. 2009. PMID: 19482249 Review.

5

Programmed cell death 4 inhibits leptin-induced breast cancer cell invasion.

González-Villasana V, Nieves-Alicea R, McMurtry V, Gutiérrez-Puente Y, Tari AM. González-Villasana V, et al. Among authors: tari am. Oncol Rep. 2012 Mar;27(3):861-6. doi: 10.3892/or.2011.1600. Epub 2011 Dec 21. Oncol Rep. 2012. PMID: 22200873

6

N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.

Simeone AM, Colella S, Krahe R, Johnson MM, Mora E, Tari AM. Simeone AM, et al. Among authors: tari am. Carcinogenesis. 2006 Mar;27(3):568-77. doi: 10.1093/carcin/bgi233. Epub 2005 Sep 30. Carcinogenesis. 2006. PMID: 16199439

7

Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells.

McMurtry V, Simeone AM, Nieves-Alicea R, Tari AM. McMurtry V, et al. Among authors: tari am. Clin Exp Metastasis. 2009;26(3):197-204. doi: 10.1007/s10585-008-9231-x. Epub 2008 Dec 27. Clin Exp Metastasis. 2009. PMID: 19112600

8

Bcl-2 inhibits p53 nuclear import following DNA damage.

Beham A, Marin MC, Fernandez A, Herrmann J, Brisbay S, Tari AM, Lopez-Berestein G, Lozano G, Sarkiss M, McDonnell TJ. Beham A, et al. Among authors: tari am. Oncogene. 1997 Dec 4;15(23):2767-72. doi: 10.1038/sj.onc.1201464. Oncogene. 1997. PMID: 9419967

9

Cyclooxygenase-2 utilizes Jun N-terminal kinases to induce invasion, but not tamoxifen resistance, in MCF-7 breast cancer cells.

Gonzalez-Villasana V, Gutiérrez-Puente Y, Tari AM. Gonzalez-Villasana V, et al. Among authors: tari am. Oncol Rep. 2013 Sep;30(3):1506-10. doi: 10.3892/or.2013.2549. Epub 2013 Jun 19. Oncol Rep. 2013. PMID: 23783392

10

Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.

Sugimoto T, Bartholomeusz C, Tari AM, Ueno NT. Sugimoto T, et al. Among authors: tari am. Breast Cancer Res. 2007;9(4):R41. doi: 10.1186/bcr1739. Breast Cancer Res. 2007. PMID: 17612393 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results